NCT02417935View on ClinicalTrials.gov

A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)

PHASE4CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 13, 2017

Study Completion Date

May 13, 2017

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
DRUG

Duloxetine

Administered orally

DRUG

Pregabalin

Administered orally

DRUG

Placebo

Administered orally

Sponsors

Collaborators (1)

Shionogi
All Listed Sponsors
collaborator

Shionogi

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY